Study of Talabostat in Advanced Melanoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
MelanomaSkin Cancer
Interventions
DRUG

talabostat (PT-100) tablets

Trial Locations (6)

60637

University of Chicago, Chicago

75246

Mary Crowley Medical Research Center, Dallas

30322-1013

Emory University/Winship Cancer Institute, Atlanta

48109-0473

University of Michigan, Ann Arbor

03756-0001

Dartmouth-Hitchcock Medical Center, Lebanon

15213-2582

University of Pittsburgh, Pittsburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Point Therapeutics

INDUSTRY